This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Cautery in epistaxis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Used in patients with epistaxis refractory to first aid methods (1).

Prior to cautery, ask the patient to blow the nose to clear out any clots and the nasal cavity should be sprayed with local anaesthetics which should ideally include a vasoconstrictor (1).

There are two main methods

  • chemical cautery with silver nitrate
    • silver nitrate stick is applied to the bleeding point with firm pressure for 5-10 seconds (2)
    • used for mild active bleeding or after active bleeding has been stopped and prominent vessels have been identified
    • avoid touching other areas like facial skin, nasal alae, or other nasal mucosae (3)
    • excess chemical is removed to avoid staining of the vestibule or upper lip (2)
  • electrocautery (2)
    • done by otolaryngoiogists under local anaesthetics
    • used in severe nose bleeds not controlled by chemical cautery (1)
    • uses radiation to seal the bleeding vessels (rather than direct contact)
    • damage to the anterior nares and inferior turbinate can occur as complications (2)

The risk of iatrogenic septal perforation is minimized by cauterizing one side of the septum at a time.

The interval between cautery treatments should be four to six weeks (2)

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.